Skip to main content

Primary Care: Kidney Risk Assessment

AAHIVM Course Banner
1.0 CEUs
Kidney Risk Assessment

Module Description  These days, many people with HIV prefer to see the same medical provider to treat their HIV and primary care needs. The Academy's Primary Care and HIV modules highlight the special considerations that HIV Specialists addressing the primary care needs of their patents and informs the Primary Care Providers about the unique considerations of people with HIV.

Credit Dates 12/19//2023 – 12/31/2024

Jointly provided by Partners for Advancing Clinical Education (PACE) and the American Academy of HIV Medicine.

This activity is supported by an independent educational grant from ViiV Healthcare.
Learning Objectives
  • Identify the epidemiology and risk factors for kidney disease in people with HIV (PWH)
  • Compare and contrast assessment strategies for kidney disease in PWH
  • Distinguish among the broad pathologic spectrum of kidney diseases in PWH
  • Discuss how antiretroviral therapy (ART) may contribute to kidney abnormalities in PWH

Target Audience
This activity is intended for Physicians, PAs, NPs, RNs, and Pharmacists who are engaged in the care of people with HIV.

Estimated Time to Complete the Activity: 60 minutes

PresentersMolly Fisher, DO
Montefiore Medical Center
Bronx, NY

Instructions for Credit
There are no fees for participating and receiving CME/CE credit for this activity.

Participation in this self-study activity should be completed in approximately XX hour. To successfully complete this activity and receive CE credit, learners must follow these steps during the period from December 19, 2023 through December 31, 2024:
  1. Review the objectives and disclosures
  2. Study the educational content
  3. Visit
  4. Complete the activity evaluation
For Pharmacists: Upon successfully completing the post-test (if applicable) with a score of 75% or better and the online evaluation, your credit will be submitted to CPE Monitor. Please check your NABP account within thirty (30) days to make sure the credit has posted.

If you have questions regarding the certification of this activity, please contact PACE by visiting ttps://

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and the American Academy of HIV Medicine. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education PACE designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education PACE designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008073-9999-23-314-H02-P)
Type of Activity: Knowledge

Continuing Nursing Education The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hours, 0.25 pharmacotherapy credits for APRN.

Disclosure of Conflict of Interest
PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Dr. Fisher has nothing to disclose.

Planners and Managers
The PACE planners and managers have nothing to disclose.
The Academy planners and managers have nothing to disclose.

Media: Internet

Computer System Requirements
This program requires the use of an internet-connected computer or device and a modern web browser capable of streaming video.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.